ISSN Print 2713-2757
ISSN Online 2713-2765
SCIENTIFIC AND PRACTICAL REVIEWED JOURNAL OF FMBA OF RUSSIA
Copyright: © 2021 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
REVIEW
Cardiovascular comorbidity in patients with nonalcoholic fatty liver disease
About authors
1 Volgograd Medical Clinical Center of FMBA, Volgograd, Russia
2 Volgograd State Medical University, Volgograd, Russia
Correspondence should be addressed: Elena E. Gorbacheva
Kim, d. 24, k. 125, Volgograd, 400001, Russia; ur.xednay@1ilsak
About paper
Author contribution: Ledovskaya TI — conceived the idea, performed data analysis and interpretation; Statsenko ME, Turkina SV — formulated the problem and organized the study; Konyakhina TA — performed literature analysis and research conceptualization; Yusupov KS — searched the literature and wrote the manuscript; Gorbacheva EE — performed data analysis and interpretation.
Received: 2021-12-07
Accepted: 2021-12-20
Published online: 2021-12-22
|
Fig. Possible mechanisms underlying cardiovascular complications in patients with NAFLD. PAI-1 — plasminogen activator inhibitor-1; TGFβ — transforming growth factor β; IL6 — interleukin 6; IR — insulin resistance; FFA — free fatty acids; LV — left ventricle; VLDL_C — very-low-density lipoprotein cholesterol, HDL_C — high-density lipoprotein cholesterol, CRP — С-reactive protein
